Pennsylvania Levaquin Plaintiffs Seek Mass Tort for Antibiotic Peripheral Neuropathy Claims
Dozens of plaintiffs currently pursuing Avelox, Cipro and Levaquin lawsuits in Pennsylvania state courts are seeking the creation of a mass tort program for all claims involving fluoroquinolone antibiotics and peripheral neuropathy. In a petition filed with the Philadelphia Court of Common Pleas last week, they assert that consolidation of the state’s docket will allow for more efficient discovery and avoid inconsistent pretrial rulings.
30 Pennsylvania Fluoroquinolone Cases Pending, More Expected
Court records indicate that there are already at least 30 fluoroquinolone cases pending in Pennsylvania, all which were filed on behalf of individuals who allegedly developed nerve damage or peripheral neuropathy due to their use of Levaquin and similar medications. The plaintiffs’ petition maintains that at least 30 additional cases will be filed in the near future.
“The legal theories, the operative facts and the recourse sought are identical for all the plaintiffs in the instant cases currently as well as for any case that shall be filed in this honorable court on behalf of any similarly situated plaintiff,” the petition said. “Overall, the injuries suffered and the damages sustained arise from the alike wrongdoing of the defendants.”
All of the lawsuits filed thus far in Pennsylvania claim that the manufacturers of Cipro, Avelox and Levaquin failed to provide patients and doctors with adequate warnings about the potential for peripheral neuropathy, which defendants were allegedly aware of as early as 1992. While mention of this complication was added to fluoroquinolone labels in 2004, plaintiffs claim that the wording was misleading, as it characterized peripheral neuropathy as a rare occurrence that would resolve once treatment with the antibiotics had ended. Stronger warnings would not be included on the drugs’ labeling until 2013.
Status Conference Scheduled in Federal Litigation
The filing of the Pennsylvania petition comes just as a federal multidistrict litigation involving fluoroquinolones and peripheral neuropathy gets underway in the U.S. District Court, District of Minnesota. That proceeding was scheduled to convene its first Status Conference on December 8th. At least 225 cases have been filed in the federal litigation against the manufacturers of Cipro, Levaquin and Avelox.
Bernstein Liebhard LLP is currently offering free, no-obligation legal reviews to individuals who were diagnosed with peripheral neuropathy following treatment with a fluoroquinolone antibiotic. To learn more about filing a Levaquin lawsuit, please call 877-779-1414 today.